Celularity Inc.
CELU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -7.9% | -49.8% | -37% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.8% | 8.6% | 68.9% | 59.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -373.4% | -361.7% | -135.5% | -41.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -436.7% | -427.5% | -172.9% | -73.3% |
| EPS Diluted | -0.876 | -1.021 | -0.84 | -0.595 |
| % Growth | 14.2% | -21.6% | -41.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |